#JPM22 - The gene edit­ing rev­o­lu­tion: Now it's time for hu­man da­ta to de­fine a fast-chang­ing field

John Car­roll:

Okay every­body, I’m John Car­roll. I’m the ed­i­tor of End­points News. I ap­pre­ci­ate the au­di­ence for join­ing us. I’m here with a great group of peo­ple to talk about prob­a­bly the most in­ter­est­ing thing that’s go­ing on in R&D right now with­in the whole bio­phar­ma in­dus­try. I think cer­tain­ly there’s been a tremen­dous amount of in­ter­est in it. There’s been a lot of in­ter­est in this par­tic­u­lar pan­el, I think be­cause of the peo­ple that we’ve got here for this one. I’m joined by David Liu from The Broad, Sekar Kathire­san, CEO of Verve, Patrick Hsu from Berke­ley and Nicole Gaudel­li, the gene edit­ing plat­form tech­nol­o­gy chief for Beam.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN